Latest filing published 18 Mar 2025 for Cumberland Pharmaceuticals INC, €30k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
John M. Hamm: trading record in brief
John M. Hamm is a declared insider of Cumberland Pharmaceuticals Inc (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 23 November 2021 to 16 March 2025, the count stands at 5 filings.
No open-market sale appears; the market trades are 1 purchase worth €7,943. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants.
The latest filing, published on 18 March 2025, reports a share grant of €30k in Cumberland Pharmaceuticals Inc. The last insider purchase was made public on 3 December 2021, 1,803 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 9 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John M. Hamm
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,930 shares@ US$5.4631.7% of flowCommon StockSEC:0001628280-25-013513:0
- 445 shares@ US$1.810.8% of flowCommon StockSEC:0001214659-24-005208:0
- 352 shares@ US$1.670.6% of flowCommon StockSEC:0001214659-23-016106:0
- 20,000 shares@ US$2.5954.7% of flowCommon StockSEC:0001209191-22-026140:0
- 3,800 shares@ US$2.359.2% of flowCommon StockSEC:0001209191-21-067905:0Canonical exit: 21 Feb 2022 (T+90)
5 of 5 declarations
